Consistent with this high hTERT expression in cancer stem cells, Hemminki et al. has suggested that an oncolytic adenovirus that is regulated by specific promoters for hTERT, cyclooxygenase-2 or multidrug resistance, shows efficient cytopathic activity against human breast cancer stem cells [46]. The gene discussed is PTGS2; the disease is cancer.